Patents by Inventor Jason NOGUEIRA

Jason NOGUEIRA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROBIFUNCTIONAL INHIBITORS OF E-SELECTIN AND GALECTIN-3
    Publication number: 20240150388
    Abstract: Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of an E-selectin, galectin-3, or E-selectin and galectin-3 to ligands are disclosed. For example, heterobifunctional inhibitors of E-selectin and galectin-3 are described and pharmaceutical compositions comprising at least one such agent is described.
    Type: Application
    Filed: November 7, 2023
    Publication date: May 9, 2024
    Applicant: GLYCOMIMETICS, INC.
    Inventors: John L. MAGNANI, John M. PETERSON, Arun K. SARKAR, Yusufbhai U. VOHRA, Indranath GHOSH, Jason NOGUEIRA
  • Galectin-3 inhibiting c-glycosides
    Patent number: 11873317
    Abstract: Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of galectin-3 to ligands are disclosed. For example, inhibitors of galectin-3 are described and pharmaceutical compositions comprising at least one such agent is described.
    Type: Grant
    Filed: December 26, 2019
    Date of Patent: January 16, 2024
    Assignee: GLYCOMIMETICS, INC.
    Inventors: John L. Magnani, John M. Peterson, Arun K. Sarkar, Yusufbhai U. Vohra, Indranath Ghosh, Jason Nogueira
  • Heterobifunctional inhibitors of E-selectin and galectin-3
    Patent number: 11845771
    Abstract: Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of an E-selectin, galectin-3, or E-selectin and galectin-3 to ligands are disclosed. For example, heterobifunctional inhibitors of E-selectin and galectin-3 are described and pharmaceutical compositions comprising at least one such agent is described.
    Type: Grant
    Filed: December 26, 2019
    Date of Patent: December 19, 2023
    Assignee: GLYCOMIMETICS, INC.
    Inventors: John L. Magnani, John M. Peterson, Arun K. Sarkar, Yusufbhai U. Vohra, Indranath Ghosh, Jason Nogueira
  • GALECTIN-3 INHIBITING C-GLYCOSIDE KETONES, ETHERS, AND ALCOHOLS
    Publication number: 20230091472
    Abstract: Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of galectin-3 to ligands are disclosed. For example, inhibitors of galectin-3 are described and pharmaceutical compositions comprising at least one such agent are described.
    Type: Application
    Filed: December 23, 2020
    Publication date: March 23, 2023
    Applicant: GLYCOMIMETICS, INC.
    Inventors: John L. MAGNANI, John M. PETERSON, Yusuf U. VOHRA, lndranath GHOSH, Jason NOGUEIRA, Arun K. SARKAR, Debatosh MAJUMDAR
  • HETEROBIFUNCTIONAL INHIBITORS OF E-SELECTIN AND GALECTIN-3
    Publication number: 20220089633
    Abstract: Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of an E-selectin, galectin-3, or E-selectin and galectin-3 to ligands are disclosed. For example, heterobifunctional inhibitors of E-selectin and galectin-3 are described and pharmaceutical compositions comprising at least one such agent is described.
    Type: Application
    Filed: December 26, 2019
    Publication date: March 24, 2022
    Applicant: GLYCOMIMETICS, INC.
    Inventors: John L. MAGNANI, John M. PETERSON, Arun K. SARKAR, Yusufbhai U. VOHRA, Indranath GHOSH, Jason NOGUEIRA
  • GALECTIN-3 INHIBITING C-GLYCOSIDES
    Publication number: 20220073555
    Abstract: Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of galectin-3 to ligands are disclosed. For example, inhibitors of galectin-3 are described and pharmaceutical compositions comprising at least one such agent is described.
    Type: Application
    Filed: December 26, 2019
    Publication date: March 10, 2022
    Applicant: GLYCOMIMETICS, INC.
    Inventors: John L. MAGNANI, John M. PETERSON, Arun K. SARKAR, Yusufbhai U. VOHRA, Indranath GHOSH, Jason NOGUEIRA